← Back to Search

Behavioural Intervention

TENS Treatment Arm for Overactive Bladder (OAB Aim 2 Trial)

N/A
Waitlist Available
Research Sponsored by Theranova, L.L.C.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 8 weeks
Awards & highlights

Summary

This pilot clinical study, which focuses on feasibility and proof-of-principle, will be conducted in 11 female subjects (55-100 years old) with UI. Subjects will use the device three times a week for 8 weeks and complete 3-day "voiding diaries" to record instances of UI episodes and OAB quality of life.

Eligible Conditions
  • Overactive Bladder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Change in Health-related Quality of Life (HRQL)
Change in Micturitions Per Day

Trial Design

1Treatment groups
Experimental Treatment
Group I: TENS Treatment ArmExperimental Treatment1 Intervention
This study is an early feasibility study which will be treating all patients at least 3 times per week, for 8 weeks, using the device.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TENS
2011
Completed Phase 2
~2040

Find a Location

Who is running the clinical trial?

Stanford UniversityOTHER
2,448 Previous Clinical Trials
17,492,376 Total Patients Enrolled
Theranova, L.L.C.Lead Sponsor
11 Previous Clinical Trials
451 Total Patients Enrolled
~3 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top